$16.92
-0.22-1.28%
At close: -
$17.31
0.392.30%
After Hours: Dec 20, 5:58 PM EDT
Companies issue guidance, or expectations of future EPS and revenue, so investors have a sense of how much money a company will make in a future period.
The most recent guidance for Medifast (MED) was reported on November 4, 2024 for Q4 2024. The company provided earnings per share guidance in the range of $0.10 to $0.65, compared to the estimated EPS of $-0.18. Additionally, Medifast forecasted revenue between $0.10B and $0.12B for the quarter.
Browse guidance and forecast on all stocks.